Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell TransplantationXu Tan, Shifeng Lou, Xi Zhang et al.|Current Medical Science|2023Cited by 8
Efficacy and Safety of Hetrombopag Versus Thrombopoietin in Promoting Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical TrialYimei Feng, Xi Zhang, Hai Yi et al.|American Journal of Hematology|2025Cited by 5